Premium
Letter: tofacitinib in biologic‐experienced ulcerative colitis—a single‐centre real‐world experience in Australia
Author(s) -
Lo S. W.,
Connell W.,
Kamm M. A.,
Lust M.,
Wright E. K.
Publication year - 2021
Publication title -
alimentary pharmacology and therapeutics
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.16468
Subject(s) - tofacitinib , ulcerative colitis , medicine , dermatology , gastroenterology , rheumatoid arthritis , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom